Medscape1d
Skin Rashes in a Patient With Antibodies to Ro/SS-A
The patient is a 45-year-old Caucasian male with a 5-year history of systemic lupus erythematosus (SLE). He has flat erythema that is more prominent on the upper chest, neck, and head. The rash ...
Yahoo Finance27d
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis
RO, ROG; OTCQX: RHHBY) announced today positive topline results from the phase III REGENCY study of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis. In the study ...
Morningstar27d
Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis
RO, ROG; OTCQX: RHHBY), announced today positive topline results from the Phase III REGENCY study of Gazyva® (obinutuzumab) in people with active lupus nephritis. In the study, a higher ...
Medscape4d
Late-onset Lupus: Facts and Fiction
Lupus in minorities: nature versus nurture [Unpublished ... and hypocomplementemia and a higher frequency of RF and of anti-Ro and anti-La antibodies Patients with late-onset disease exhibit ...
KYW Radio Philadelphia on MSN29d
Medical Report: How hydroxychloroquine is being used to treat lupus
PHILADELPHIA (KYW Newsradio) — A newly released report from French researchers found hydroxychloroquine — the controversial ...
verywellhealth6d
What Doctors Treat Lupus?
Since most people with lupus end up seeing a number of different specialists ... Anti-Smith (anti-Sm) Anti-U1RNP Anti-Ro/SSA Anti-La/SSB Some labs will also test for anti-nucleoprotein, ...
lupus.bmj13d
Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE
Patient 1 is a 35-year-old female with Fitzpatrick skin-type V and a 17-year history of SLE, based on class II lupus nephritis (LN), CLE, leucopenia, ANA 1:640, anti-dsDNA, anti-Smith, ...
BioSpace27d
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis
RO, ROG; OTCQX: RHHBY) announced today positive topline results from the phase III REGENCY study of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis. In the study, a higher ...
BioSpace27d
Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis
--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from the Phase III REGENCY study of Gazyva® (obinutuzumab) in people ...
Daily26d
Hydroxychloroquine Fails to Lower Pre-eclampsia Risk in Women with Lupus, Study Finds
USA: A recent study examining the effects of hydroxychloroquine (HCQ) on pre-eclampsia in a diverse cohort of women with systemic lupus erythematosus (SLE) has provided critical insights, although it ...
lupus.bmj29d
Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis
class of lupus nephritis, and neurological manifestation), positive autoantibodies (ANA, anti-double stranded DNA (anti-ds-DNA) antibody, anti-Smith (anti-Sm) antibody, anti-SSA/Ro antibody, ...